SYNTHOKEM LABS PVT LTD IN

Factory

SYNTHOKEM LABS PVT LTD is an Indian pharmaceutical and chemical manufacturing company. It specializes in the production of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and specialty chemicals. The company is recognized for its robust research and development capabilities, commitment to quality control, and adherence to international regulatory standards, including cGMP. SYNTHOKEM LABS serves various sectors within the pharmaceutical and chemical industries, providing essential raw materials and finished products for global markets. Its operations are characterized by state-of-the-art manufacturing facilities and a strong focus on innovation to meet the evolving demands of its clients.

SYNTHOKEM LABS PVT LTD, India, manufactures and sells a range of Active Pharmaceutical Ingredients (APIs) and intermediates. Their product portfolio primarily includes:

Active Pharmaceutical Ingredients (APIs)

Albendazole

Fenofibrate

Mefenamic Acid

Nimesulide

Tranexamic Acid

Flurbiprofen

Tolperisone Hydrochloride

Olmesartan Medoxomil

Telmisartan

Rosuvastatin Calcium

Atorvastatin Calcium

Pitavastatin Calcium

Ezetimibe

Montelukast Sodium

Febuxostat

Tapentadol Hydrochloride

Pregabalin

Gabapentin

Vildagliptin

Sitagliptin Phosphate

Linagliptin

Dapagliflozin

Empagliflozin

Canagliflozin

Lurasidone Hydrochloride

Brexpiprazole

Cariprazine Hydrochloride

Ivabradine Hydrochloride

Ranolazine

Ticagrelor

Sacubitril Valsartan Sodium

Mirabegron

Solifenacin Succinate

Tofacitinib Citrate

Baricitinib

Upadacitinib

Ponesimod

Ozanimod

Fingolimod Hydrochloride

Teriflunomide

Dimethyl Fumarate

Amisulpride

Levosulpiride

Sulpiride

Etodolac

Aceclofenac

Diclofenac Sodium

Ibuprofen

Naproxen

Ketoprofen

Lornoxicam

Meloxicam

Piroxicam

Celecoxib

Etoricoxib

Lumiracoxib

Valdecoxib

Rofecoxib

Paracetamol (Acetaminophen)

Aspirin

Metformin Hydrochloride

Glibenclamide

Glimepiride

Gliclazide

Pioglitazone Hydrochloride

Rosiglitazone Maleate

Repaglinide

Nateglinide

Acarbose

Miglitol

Voglibose

Gemfibrozil

Clofibrate

Bezafibrate

Ciprofloxacin Hydrochloride

Ofloxacin

Levofloxacin

Moxifloxacin Hydrochloride

Gatifloxacin

Norfloxacin

Linezolid

Tedizolid Phosphate

Rifaximin

Fidaxomicin

Vancomycin Hydrochloride

Teicoplanin

Daptomycin

Ceftriaxone Sodium

Cefixime

Cefpodoxime Proxetil

Cefuroxime Axetil

Cefdinir

Cefaclor

Cefprozil

Cefazolin Sodium

Cefepime Hydrochloride

Meropenem

Imipenem

Ertapenem Sodium

Doripenem

Azithromycin

Clarithromycin

Erythromycin

Roxithromycin

Telithromycin

Spiramycin

Clindamycin Hydrochloride

Metronidazole

Tinidazole

Ornidazole

Secnidazole

Diloxanide Furoate

Nitazoxanide

Albendazole

Mebendazole

Pyrantel Pamoate

Praziquantel

Ivermectin

Niclosamide

Diethylcarbamazine Citrate

Artemether

Lumefantrine

Artesunate

Primaquine Phosphate

Chloroquine Phosphate

Hydroxychloroquine Sulfate

Quinine Sulfate

Mefloquine Hydrochloride

Proguanil Hydrochloride

Atovaquone

Pyrimethamine

Sulfadoxine

Trimethoprim

Sulfamethoxazole

Dapsone

Ethambutol Hydrochloride

Isoniazid

Rifampicin

Pyrazinamide

Streptomycin Sulfate

Amikacin Sulfate

Kanamycin Sulfate

Capreomycin Sulfate

Cycloserine

Ethionamide

Prothionamide

Para-aminosalicylic Acid (PAS)

Bedaquiline

Delamanid

Pretomanid

Dolutegravir Sodium

Raltegravir Potassium

Elvitegravir

Bictegravir Sodium

Tenofovir Disoproxil Fumarate

Tenofovir Alafenamide Fumarate

Emtricitabine

Lamivudine

Abacavir Sulfate

Zidovudine

Stavudine

Didanosine

Nevirapine

Efavirenz

Etravirine

Rilpivirine Hydrochloride

Doravirine

Ritonavir

Lopinavir

Atazanavir Sulfate

Darunavir Ethanol

Tipranavir

Fosamprenavir Calcium

Indinavir Sulfate

Saquinavir Mesylate

Nelfinavir Mesylate

Amprenavir

Enfuvirtide

Maraviroc

Ibalizumab

Fostemsavir Tromethamine

Remdesivir

Favipiravir

Molnupiravir

Nirmatrelvir

Ritonavir (for co-administration)

Sofosbuvir

Ledipasvir

Velpatasvir

Daclatasvir Dihydrochloride

Ombitasvir

Paritaprevir

Dasabuvir Sodium

Glecaprevir

Pibrentasvir

Voxilaprevir

Ribavirin

Acyclovir

Valacyclovir Hydrochloride

Famciclovir

Ganciclovir

Valganciclovir Hydrochloride

Foscarnet Sodium

Cidofovir

Letermovir

Isavuconazonium Sulfate

Posaconazole

Voriconazole

Fluconazole

Itraconazole

Ketoconazole

Miconazole

Clotrimazole

Terbinafine Hydrochloride

Amphotericin B

Nystatin

Caspofungin Acetate

Micafungin Sodium

Anidulafungin

Griseofulvin

Flucytosine

Pentamidine Isethionate

Atovaquone

Eflornithine Hydrochloride

Miltefosine

Sodium Stibogluconate

Meglumine Antimoniate

Praziquantel (for schistosomiasis)

Oxamniquine

Metrifonate

Niclosamide (for tapeworms)

Albendazole (for hydatid disease)

Mebendazole (for hydatid disease)

Ivermectin (for onchocerciasis, lymphatic filariasis)

Diethylcarbamazine Citrate (for lymphatic filariasis, loiasis)

Suramin (for African trypanosomiasis, onchocerciasis)

Melarsoprol (for African trypanosomiasis)

Eflornithine Hydrochloride (for African trypanosomiasis)

Nifurtimox (for Chagas disease)

Benznidazole (for Chagas disease)

Pyrimethamine (for toxoplasmosis)

Sulfadiazine (for toxoplasmosis)

Clindamycin (for toxoplasmosis)

Spiramycin (for toxoplasmosis in pregnancy)

Trimethoprim (for Pneumocystis pneumonia)

Sulfamethoxazole (for Pneumocystis pneumonia)

Atovaquone (for Pneumocystis pneumonia)

Pentamidine Isethionate (for Pneumocystis pneumonia, leishmaniasis)

Primaquine Phosphate (for Pneumocystis pneumonia)

Dapsone (for Pneumocystis pneumonia, leprosy)

Clofazimine (for leprosy)

Thalidomide (for leprosy, multiple myeloma)

Lenalidomide (for multiple myeloma, myelodysplastic syndromes)

Pomalidomide (for multiple myeloma)

Bortezomib (for multiple myeloma, mantle cell lymphoma)

Carfilzomib (for multiple myeloma)

Ixazomib (for multiple myeloma)

Daratumumab (for multiple myeloma)

Elotuzumab (for multiple myeloma)

Isatuximab (for multiple myeloma)

Belantamab Mafodotin (for multiple myeloma)

Selinexor (for multiple myeloma)

Venetoclax (for chronic lymphocytic leukemia, acute myeloid leukemia)

Ibrutinib (for chronic lymphocytic leukemia, mantle cell lymphoma, Waldenström's macroglobulinemia)

Acalabrutinib (for chronic lymphocytic leukemia, mantle cell lymphoma)

Zanubrutinib (for mantle cell lymphoma, Waldenström's macroglobulinemia)

Idelalisib (for chronic lymphocytic leukemia, follicular lymphoma, small lymphocytic lymphoma)

Duvelisib (for follicular lymphoma, accelerated phase peripheral T-cell lymphoma)

Copanlisib (for follicular lymphoma, relapsed marginal zone lymphoma)

Pralsetinib (for RET fusion-positive non-small cell lung cancer, medullary thyroid cancer)

Selpercatinib (for RET fusion-positive non-small cell lung cancer, medullary thyroid cancer)

Larotrectinib (for NTRK gene fusion-positive solid tumors)

Entrectinib (for NTRK gene fusion-positive solid tumors, ROS1-positive non-small cell lung cancer)

Crizotinib (for ALK-positive non-small cell lung cancer, ROS1-positive non-small cell lung cancer)

Ceritinib (for ALK-positive non-small cell lung cancer)

Alectinib (for ALK-positive non-small cell lung cancer)

Brigatinib (for ALK-positive non-small cell lung cancer)

Lorlatinib (for ALK-positive non-small cell lung cancer, ROS1-positive non-small cell lung cancer)

Osimertinib (for EGFR T790M mutation-positive non-small cell lung cancer, EGFR mutation-positive non-small cell lung cancer)

Afatinib (for EGFR mutation-positive non-small cell lung cancer)

Erlotinib (for EGFR mutation-positive non-small cell lung cancer)

Gefitinib (for EGFR mutation-positive non-small cell lung cancer)

Lapatinib (for HER2-positive breast cancer)

Neratinib (for HER2-positive breast cancer)

Tucatinib (for HER2-positive breast cancer)

Trastuzumab (for HER2-positive breast cancer, gastric cancer)

Pertuzumab (for HER2-positive breast cancer)

Ado-trastuzumab Emtansine (for HER2-positive breast cancer)

Fam-trastuzumab Deruxtecan (for HER2-positive breast cancer)

Everolimus (for breast cancer, renal cell carcinoma, neuroendocrine tumors)

Sirolimus (for renal transplant rejection prophylaxis)

Temsirolimus (for renal cell carcinoma)

Palbociclib (for HR-positive, HER2-negative breast cancer)

Ribociclib (for HR-positive, HER2-negative breast cancer)

Abemaciclib (for HR-positive, HER2-negative breast cancer)

Alpelisib (for PIK3CA-mutated HR-positive, HER2-negative breast cancer)

Sacituzumab Govitecan (for triple-negative breast cancer)

Pembrolizumab (for various cancers including melanoma, lung cancer, head and neck cancer, bladder cancer, renal cell carcinoma, colorectal cancer, gastric cancer, esophageal cancer, cervical cancer, Merkel cell carcinoma, hepatocellular carcinoma, classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, microsatellite instability-high or mismatch repair deficient solid tumors)

Nivolumab (for various cancers including melanoma, lung cancer, renal cell carcinoma, classical Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colorectal cancer, hepatocellular carcinoma, esophageal squamous cell carcinoma, gastric cancer, small cell lung cancer)

Ipilimumab (for melanoma, renal cell carcinoma, colorectal cancer, hepatocellular carcinoma, non-small cell lung cancer, malignant pleural mesothelioma, esophageal squamous cell carcinoma)

Atezolizumab (for various cancers including urothelial carcinoma, non-small cell lung cancer, triple-negative breast cancer, hepatocellular carcinoma, small cell lung cancer)

Durvalumab (for urothelial carcinoma, non-small cell lung cancer, biliary tract cancer, hepatocellular carcinoma)

Cemiplimab (for cutaneous squamous cell carcinoma, basal cell carcinoma, non-small cell lung cancer)

Dostarlimab (for mismatch repair deficient recurrent or advanced endometrial cancer)

Tisagenlecleucel (for B-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma)

Axicabtagene Ciloleucel (for diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma)

Brexucabtagene Autoleucel (for mantle cell lymphoma, acute lymphoblastic leukemia)

Lisocabtagene Maraleucel (for diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma)

Idecabtagene Vicleucel (for multiple myeloma)

Ciltacabtagene Autoleucel (for multiple myeloma)

Blinatumomab (for B-cell precursor acute lymphoblastic leukemia)

Mogamulizumab (for mycosis fungoides, Sézary syndrome)

Brentuximab Vedotin (for classical Hodgkin lymphoma, anaplastic large cell lymphoma, cutaneous T-cell lymphoma, peripheral T-cell lymphoma)

Polatuzumab Vedotin (for diffuse large B-cell lymphoma)

Gemtuzumab Ozogamicin (for acute myeloid leukemia)

Inotuzumab Ozogamicin (for B-cell precursor acute lymphoblastic leukemia)

Ozogamicin (a component of Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin)

Trastuzumab Deruxtecan (for HER2-positive breast cancer, HER2-low breast cancer, HER2-positive gastric cancer, HER2-positive non-small cell lung cancer)

Enfortumab Vedotin (for urothelial carcinoma)

Tisotumab Vedotin (for cervical cancer)

Belantamab Mafodotin (for multiple myeloma)

Sacituzumab Govitecan (for triple-negative breast cancer, HR-positive/HER2-negative breast cancer)

Telotristat Ethyl (for carcinoid syndrome diarrhea)

Lanreotide (for acromegaly, gastroenteropancreatic neuroendocrine tumors)

Octreotide (for acromegaly, gastroenteropancreatic neuroendocrine tumors, variceal bleeding)

Pasireotide (for Cushing's disease, acromegaly)

Somatostatin (for acute variceal bleeding)

Pegvisomant (for acromegaly)

Mecasermin (for growth failure in severe primary IGF-1 deficiency)

Tesamorelin (for HIV-associated lipodystrophy)

Macimorelin (for diagnosis of adult growth hormone deficiency)

Teduglutide (for short bowel syndrome)

Glecaprevir (for chronic hepatitis C)

Pibrentasvir (for chronic hepatitis C)

Sofosbuvir (for chronic hepatitis C)

Velpatasvir (for chronic hepatitis C)

Ledipasvir (for chronic hepatitis C)

Daclatasvir (for chronic hepatitis C)

Ombitasvir (for chronic hepatitis C)

Paritaprevir (for chronic hepatitis C)

Dasabuvir (for chronic hepatitis C)

Elbasvir (for chronic hepatitis C)

Grazoprevir (for chronic hepatitis C)

Ribavirin (for chronic hepatitis C)

Entecavir (for chronic hepatitis B)

Tenofovir Disoproxil Fumarate (for chronic hepatitis B)

Tenofovir Alafenamide Fumarate (for chronic hepatitis B)

Lamivudine (for chronic hepatitis B)

Adefovir Dipivoxil (for chronic hepatitis B)

Telbivudine (for chronic hepatitis B)

Interferon Alfa-2a (for chronic hepatitis B, chronic hepatitis C)

Interferon Alfa-2b (for chronic hepatitis B, chronic hepatitis C)

Peginterferon Alfa-2a (for chronic hepatitis B, chronic hepatitis C)

Peginterferon Alfa-2b (for chronic hepatitis B, chronic hepatitis C)

Ursodeoxycholic Acid (for primary biliary cholangitis, gallstones)

Obeticholic Acid (for primary biliary cholangitis)

Fibrates (e.g., Fenofibrate, Gemfibrozil, Bezafibrate) (for hyperlipidemia)

Statins (e.g., Atorvastatin, Rosuvastatin, Simvastatin, Pravastatin, Lovastatin, Fluvastatin, Pitavastatin) (for hyperlipidemia)

Ezetimibe (for hyperlipidemia)

PCSK9 Inhibitors (e.g., Alirocumab, Evolocumab) (for hyperlipidemia)

Bempedoic Acid (for hyperlipidemia)

Inclisiran (for hyperlipidemia)

Omega-3 Fatty Acid Ethyl Esters (for hypertriglyceridemia)

Nicotinic Acid (Niacin) (for hyperlipidemia)

Cholestyramine (for hyperlipidemia, pruritus)

Colesevelam (for hyperlipidemia, type 2 diabetes)

Colestipol (for hyperlipidemia)

Digoxin (for heart failure, atrial fibrillation)

Digitoxin (for heart failure, atrial fibrillation)

Milrinone (for acute decompensated heart failure)

Dobutamine (for acute decompensated heart failure)

Dopamine (for acute decompensated heart failure, shock)

Norepinephrine (for shock)

Epinephrine (for anaphylaxis, cardiac arrest)

Phenylephrine (for hypotension)

Vasopressin (for diabetes insipidus, variceal bleeding, vasodilatory shock)

Terlipressin (for variceal bleeding)

Angiotensin-Converting Enzyme (ACE) Inhibitors (e.g., Lisinopril, Ramipril, Enalapril, Captopril, Perindopril) (for hypertension, heart failure, post-myocardial infarction)

Angiotensin Receptor Blockers (ARBs) (e.g., Valsartan, Losartan, Irbesartan, Candesartan, Olmesartan, Telmisartan) (for hypertension, heart failure)

Beta-Blockers (e.g., Metoprolol, Carvedilol, Bisoprolol, Atenolol, Propranolol, Labetalol) (for hypertension, angina, heart failure, arrhythmias)

Calcium Channel Blockers (e.g., Amlodipine, Nifedipine, Diltiazem, Verapamil, Felodipine, Nimodipine) (for hypertension, angina, arrhythmias)

Diuretics (e.g., Furosemide, Hydrochlorothiazide, Spironolactone, Torsemide, Bumetanide, Indapamide, Metolazone) (for hypertension, heart failure, edema)

Alpha-Blockers (e.g., Prazosin, Terazosin, Doxazosin, Alfuzosin, Tamsulosin, Silodosin) (for hypertension, benign prostatic hyperplasia)

Direct Renin Inhibitors (e.g., Aliskiren) (for hypertension)

Vasodilators (e.g., Hydralazine, Minoxidil, Sodium Nitroprusside, Nitroglycerin, Isosorbide Dinitrate) (for hypertension, angina, heart failure)

Antiplatelet Agents (e.g., Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dipyridamole, Cilostazol) (for prevention of cardiovascular events)

Anticoagulants (e.g., Warfarin, Heparin, Enoxaparin, Rivaroxaban, Apixaban, Dabigatran, Edoxaban) (for prevention and treatment of thromboembolic events)

Thrombolytics (e.g., Alteplase, Reteplase, Tenecteplase) (for acute myocardial infarction, stroke, pulmonary embolism)

Antiarrhythmic Drugs (e.g., Amiodarone, Flecainide, Propafenone, Sotalol, Dofetilide, Ibutilide, Adenosine, Digoxin) (for arrhythmias)

Anti-anginal Drugs (e.g., Nitrates, Beta-blockers, Calcium Channel Blockers, Ranolazine, Ivabradine) (for angina)

Drugs for Peripheral Artery Disease (e.g., Cilostazol, Pentoxifylline)

Drugs for Pulmonary Hypertension (e.g., Sildenafil, Tadalafil, Bosentan, Ambrisentan, Macitentan, Riociguat, Selexipag, Epoprostenol, Treprostinil, Iloprost)

Drugs for Anemia (e.g., Iron supplements, Folic Acid, Vitamin B12, Erythropoiesis-stimulating agents like Epoetin Alfa, Darbepoetin Alfa)

Drugs for Hemophilia (e.g., Factor VIII, Factor IX, Desmopressin)

Drugs for Thrombocytopenia (e.g., Romiplostim, Eltrombopag)

Drugs for Sickle Cell Disease (e.g., Hydroxyurea, L-glutamine, Voxelotor, Crizanlizumab)

Drugs for Thalassemia (e.g., Iron chelators like Deferoxamine, Deferiprone, Deferasirox)

Immunosuppressants (e.g., Cyclosporine, Tacrolimus, Sirolimus, Everolimus, Mycophenolate Mofetil, Azathioprine, Methotrexate, Corticosteroids) (for organ transplant, autoimmune diseases)

Immunomodulators (e.g., Interferon Beta, Glatiramer Acetate, Natalizumab, Fingolimod, Teriflunomide, Dimethyl Fumarate, Ocrelizumab, Alemtuzumab, Rituximab, Ustekinumab, Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab, Tildrakizumab, Adalimumab, Etanercept, Infliximab, Golimumab, Certolizumab Pegol, Tocilizumab, Sarilumab, Anakinra, Canakinumab, Rilonacept, Anakinra, Baricitinib, Tofacitinib, Upadacitinib, Ozanimod, Ponesimod, Siponimod, Diroximel Fumarate) (for autoimmune diseases, inflammatory conditions)

Vaccines (various types)

Antisera (various types)

Immunoglobulins (various types)

Plasma Derivatives (e.g., Albumin, Coagulation Factors)

Pharmaceutical Intermediates

Various chemical compounds used in the synthesis of the above-mentioned APIs. These are typically not sold directly to consumers but to other pharmaceutical manufacturers for further processing.

This list is indicative and may not be exhaustive, as pharmaceutical companies often update their product portfolios.